Other studies have shown a relationship between high levels of uric acid and pulmonary arterial hypertension (PAH). This study looked at...

This study looked at the challenges and impacts of non-oral treatments for pulmonary arterial hypertension (PAH), beyond those caused by...

Early use of dual therapy helps newly-diagnosed pulmonary arterial hypertension patients do as well as patients six months past...

Since the 1980s, treatment options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have increased. This study...

A very small (16 patients) phase 2a clinical trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD) looked...

We know methamphetamine use is associated with pulmonary arterial hypertension (PAH), but this population's care needs haven't been...

Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily...

This systemic review summarized the data from six studies that examined whether prostacyclin analogues are safe and useful when used to...

In a small study of 34 pulmonary arterial hypertension (PAH) patients taking triple therapy plus sotatercept, some were able to stop...

A 2024 study looked at the association between socioeconomic disadvantage and pulmonary hypertension. In one New York hospital system,...

Medications for pulmonary arterial hypertension (PAH) are not approved for use in patients with pulmonary hypertension due to...

The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...

Researchers wanted to know whether an enlarged pulmonary artery could independently predict risk in pulmonary arterial hypertension (in...

Seralutinib is a molecule that blocks inflammation, cell proliferation, and scarring responsible for pulmonary arterial hypertension. The...

In a study of data from the Pulmonary Hypertension Association Registry in the US, researchers looked at who was more likely to skip...

A study looked at about 3000 pulmonary arterial hypertension patients and found that people who added selexipag to double therapy (an...

The HYPERION study examined whether adding sotatercept to other therapies for recently diagnosed patients with pulmonary arterial...

Patients with pulmonary arterial hypertension (PAH) often also have cardiovascular issues such as diabetes or heart disease. A new...

Cardiac index (CI) assesses the output of someone's heart based on their size. It measures heart function relative to the person's size...

The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...